Kristen Pallok, MD
Internal Medicine · Chicago, ILNPI 1750848461
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $255,705 of the $255,705 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Novartis. 2025 is the largest year on record at $104,895, 2.2 times the $47,914 reported in 2023. Among internal medicine clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 17 payments — averaging $15,041 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$256K
What the payments were for
- Speaking & faculty fees$255,705100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 17 | $255,705 |
How this compares
$255,705 in reported general payments places this provider in the 95th percentile of 5,182 internal medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 116 | $113,654 |
| JardianceEmpagliflozin | 47 | $57,672 |
| EliquisApixaban | 27 | $35,466 |
| TrulicityDulaglutide | 17 | $17,889 |
| Tresiba Flextouch U-100Insulin Degludec | 11 | $5,672 |
| Atorvastatin Calcium | 240 | $2,403 |
| Diclofenac Sodium | 50 | $2,175 |
| SynthroidLevothyroxine Sodium | 26 | $2,119 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 21 | $2,018 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 51 | $1,733 |
| Nifedipine ErNifedipine | 44 | $1,578 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 17 | $1,573 |
| Metoprolol Succinate | 85 | $1,455 |
| Gabapentin | 118 | $1,347 |
| Amlodipine Besylate | 187 | $1,308 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Chicago
- Merle DiamondChicago$1.1M
- Robert KushnerChicago$516K
- Romeo UrsuaChicago$420K
- Peter O DonnellChicago$318K
- George UrbanChicago$258K
- George NissanChicago$252K
- Luke LaffinChicago$162K
- Daniel CatenacciChicago$161K
- Hiren ShahChicago$144K
- Toral PatelChicago$125K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.